Results 271 to 280 of about 100,585 (295)

Acinetobacter baumannii and Acinetobacter spp.

2017
Acinetobacter baumannii is a bacterial pathogen increasingly identified in the clinical microbiology laboratory as a cause of infection in humans. Upon microscopic examination, A. baumannii appears as a Gram-negative coccobacillus, and it produces clear colonies when grown on MacConkey agar, indicating its inability to ferment lactose.
Federico Perez, Robert A. Bonomo
openaire   +2 more sources

The Rise of Carbapenem-Resistant Acinetobacter baumannii

Current Pharmaceutical Design, 2012
Acinetobacter spp. are Gram-negative bacteria that have become one of the most difficult pathogens to treat. The species A. baumannii, largely unknown 30 years ago, has risen to prominence particularly because of its ability to cause infections in immunocompromised patients.
Evans, Benjamin A., Hamouda, Ahmed, Amyes, Sebastian G. B.   +2 more
openaire   +4 more sources

Genetic Manipulation of Acinetobacter baumannii

Current Protocols in Microbiology, 2014
Abstract Acinetobacter baumannii is a Gram‐negative nosocomial pathogen of clinical importance. A lack of genetic tools has hindered the research of this organism in the past; however, recently, various methods have been designed, modified, and optimized to facilitate the genetic manipulation of A. baumannii.
Daniel V. Zurawski, Howard A. Shuman, Mitchell G. Thompson, Michael J. Gebhardt, Brendan W. Corey, Suleyman Yildirim, Anna C. Jacobs   +6 more
openaire   +3 more sources

Optimizing Therapy for Acinetobacter baumannii

Seminars in Respiratory and Critical Care Medicine, 2007
Acinetobacter baumannii is a highly resilient, gram-negative coccobacillus that thrives within the unique and complex ecological setting of an intensive care unit. This evolving pathogen has now surpassed human capacity to create new antimicrobials, and has led physicians into a concerning era for hospital-acquired infections.
openaire   +3 more sources

Quorum Sensing in Acinetobacter baumannii

2014
Acinetobacter baumannii is an opportunistic nosocomial pathogen that causes severe infections especially in patients with compromised immune systems. Many Gram-negative pathogens regulate the expression of their virulence factors through cell density dependent N-acyl homoserine lactone (AHL)-mediated quorum-sensing (QS) system. A.
Prince Sharma, Nidhi Bhargava, Neena Capalash   +2 more
openaire   +2 more sources

Acinetobacter baumannii pseudomeningitis

Heart & Lung, 2002
Burke A. Cunha, Eric A. Hansen, William M. Gusten   +2 more
openaire   +3 more sources

RecET-Mediated Recombineering in Acinetobacter baumannii

2019
Acinetobacter baumannii rapidly acquires antibiotic resistance, and its genome encodes mechanisms to tolerate biocides and desiccation, enhancing its persistence in hospital settings. Tools to rapidly dissect the A. baumannii genome are needed to understand cellular factors that contribute to its resiliency at a genetic and mechanistic level.
Bryan William Davies, Matthew J. Powers, Ashley T. Tucker, M. Stephen Trent   +3 more
openaire   +3 more sources

Vacuna frente a acinetobacter baumannii.

2022
Vacuna frente a Acinetobacter baumannii.La presente invención se refiere a una composición que comprende proteínas de la membrana externa de A. baumannii y a su uso como vacuna para la prevención de infecciones causadas por este patógeno, así como al ...
Macconnel, Michel, Pachón Díaz, Jerónimo   +1 more
openaire   +1 more source

Acinetobacter baumannii infections in children

The Lancet Infectious Diseases, 2010
Carmelo Gabriele, Fernando Maria de Benedictis, P. Osimani   +2 more
openaire   +3 more sources

Co-occurrence of Plasmid-Mediated Tigecycline and Carbapenem Resistance in Acinetobacter spp. from Waterfowls and Their Neighboring Environment

Antimicrobial Agents and Chemotherapy, 2020
Chong Chen, Bao-Tao Liu, Xiao-Ping Liao
exaly